TW200701978A - Methods of treating epileptogenesis and epilepsy - Google Patents

Methods of treating epileptogenesis and epilepsy

Info

Publication number
TW200701978A
TW200701978A TW094132376A TW94132376A TW200701978A TW 200701978 A TW200701978 A TW 200701978A TW 094132376 A TW094132376 A TW 094132376A TW 94132376 A TW94132376 A TW 94132376A TW 200701978 A TW200701978 A TW 200701978A
Authority
TW
Taiwan
Prior art keywords
group
phenyl
alkyl
epilepsy
methods
Prior art date
Application number
TW094132376A
Other languages
Chinese (zh)
Inventor
Roy E Twyman
Bo-Yu Zhao
Gerald P Novak
Yong-Moon Choi
Robert Gordon
Carlos R Plata-Salaman
Harold Steven White
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37600951&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200701978(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of TW200701978A publication Critical patent/TW200701978A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention is directed to methods for preventing, treating, reversing, inhibiting or arresting epilepsy and epileptogenesis in subject comprising administering to the subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II), or a pharmaceutically acceptable salt or ester thereof: Wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).
TW094132376A 2005-07-12 2005-09-19 Methods of treating epileptogenesis and epilepsy TW200701978A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69862505P 2005-07-12 2005-07-12
US70724205P 2005-08-11 2005-08-11

Publications (1)

Publication Number Publication Date
TW200701978A true TW200701978A (en) 2007-01-16

Family

ID=37600951

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094132376A TW200701978A (en) 2005-07-12 2005-09-19 Methods of treating epileptogenesis and epilepsy

Country Status (4)

Country Link
AR (1) AR051314A1 (en)
PE (1) PE20061039A1 (en)
TW (1) TW200701978A (en)
UY (1) UY29158A1 (en)

Also Published As

Publication number Publication date
PE20061039A1 (en) 2006-11-08
UY29158A1 (en) 2005-11-30
AR051314A1 (en) 2007-01-03

Similar Documents

Publication Publication Date Title
NO20071921L (en) Methods for treating epileptogenesis and epilepsy
WO2007008562A3 (en) Carbamate compounds for use in treating neurodegenerative disorders
TW200744575A (en) Methods of treating epileptogenesis
IL189003A0 (en) Methods for treating substance-related disorders
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
YU67703A (en) Carbamate compounds for use in preventing or treating movement disorders
IL157590A0 (en) Carbamate compounds for use in preventing or treating bipolar disorder
RS67603A (en) Carbamate compounds for use in the treatment of pain
MX2009004553A (en) Methods for treatment of cochlear and vestibular disorders.
HK1062270A1 (en) Carbamate compounds for use in preventing or treating anxiety disorders
RS67503A (en) Carbamate compounds for use in preventing of treating psychotic disorders
TW200701978A (en) Methods of treating epileptogenesis and epilepsy
HK1063435A1 (en) Carbamate compounds for use in preventing or treating neuropathic pain
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
CY1110672T1 (en) USE OF 2- FENYL-1,2-ETHANODIOL- (DI) CARBAMIC FOR SELECTION THERAPY
MY149385A (en) Methods for treating substance-related disorders